SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Zentek Ltd.
ZEN.V 1.190-1.7%2:26 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: George6910/25/2025 7:05:07 AM
3 Recommendations

Recommended By
Candu
Canseco
ValuHunter

  Read Replies (1) of 53889
 
From Google:

Triera's aptamer platform is protected by multiple patents, primarily through an exclusive license agreement with
McMaster University, which covers the use of aptamers and DNAzymes developed by the university's Li Lab. Zentek (Triera's parent company) has also filed its own provisional patents to protect innovations to the platform, such as improvements for manufacturing and high-binding affinity aptamers. The company continues to expand its patent portfolio for its discoveries.

Core intellectual property
  • Licensing agreement: Triera holds a 20-year, worldwide, exclusive license from McMaster University to practice aptamer and DNAzyme technologies developed by the Li Lab.
  • Scope: The license agreement has been amended to cover all aptamer and DNAzyme uses, including diagnostics, therapeutics, and neutralization agents.


Zentek's own patents
  • Provisional patents: Zentek has filed provisional patents to protect its innovations, including upgrades to the platform that have improved binding affinity and solved manufacturing challenges.
  • Manufacturing improvements: One patent application specifically covers innovations that have resulted in high-binding affinity (HBA) aptamers being produced with approximately a

    95%
    95%
    yield, which addresses a major roadblock for commercial products.
  • Ongoing development: The company continues to build on its patent portfolio as it makes new discoveries and innovations.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext